LuSens: a keratinocyte based ARE reporter gene assay for use in integrated testing strategies for skin sensitization hazard identification.
Toxicology in Vitro(2014)
摘要
•The LuSens assay uses a human keratinocyte ARE reporter cell line.•The LuSens addresses a key step of the adverse outcome pathway of skin sensitization.•The LuSens provides the same readout as KeratinoSens™; both can be used equivalently.•The test battery comprised of LuSens, DPRA and h-CLAT attained a predictivity similar to LLNA.
更多查看译文
关键词
Skin sensitization,Antioxidant response element (ARE),In vitro,Adverse outcome pathway (AOP),Keratinocyte activation
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要